Weixiong Yang

576 total citations
25 papers, 364 citations indexed

About

Weixiong Yang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weixiong Yang has authored 25 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Weixiong Yang's work include Esophageal Cancer Research and Treatment (10 papers), Esophageal and GI Pathology (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Weixiong Yang is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Esophageal and GI Pathology (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Weixiong Yang collaborates with scholars based in China, United States and Taiwan. Weixiong Yang's co-authors include Chao Cheng, Yu Zeng, Yiran Li, Mengting Zhu, Zhenguo Liu, Aliza Monroe‐Wise, Yan Guo, Xu He, Zhaojun Wu and Meiying Shen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Advanced Science.

In The Last Decade

Weixiong Yang

21 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weixiong Yang China 10 106 104 86 84 73 25 364
Andrea P. Malizia Italy 12 46 0.4× 59 0.6× 58 0.7× 58 0.7× 124 1.7× 24 500
Xiaoyu Hu China 11 144 1.4× 121 1.2× 63 0.7× 27 0.3× 90 1.2× 25 451
Kailian Zheng China 10 126 1.2× 48 0.5× 53 0.6× 59 0.7× 68 0.9× 26 273
Fatemeh Tajik Iran 9 57 0.5× 106 1.0× 21 0.2× 15 0.2× 55 0.8× 33 307
Philippe Sauthier Canada 13 125 1.2× 52 0.5× 42 0.5× 122 1.5× 119 1.6× 32 619
Dongsheng Zhu China 9 27 0.3× 75 0.7× 52 0.6× 45 0.5× 57 0.8× 40 297
Xi Zhu China 12 82 0.8× 25 0.2× 52 0.6× 73 0.9× 139 1.9× 40 370
Sherry Owens United States 12 141 1.3× 51 0.5× 52 0.6× 203 2.4× 148 2.0× 33 544
Lyndon Walker United Kingdom 11 117 1.1× 30 0.3× 61 0.7× 26 0.3× 58 0.8× 30 525
Rachel E. Lerner United States 11 123 1.2× 57 0.5× 94 1.1× 12 0.1× 54 0.7× 17 339

Countries citing papers authored by Weixiong Yang

Since Specialization
Citations

This map shows the geographic impact of Weixiong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiong Yang more than expected).

Fields of papers citing papers by Weixiong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixiong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiong Yang. The network helps show where Weixiong Yang may publish in the future.

Co-authorship network of co-authors of Weixiong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weixiong Yang. A scholar is included among the top collaborators of Weixiong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixiong Yang. Weixiong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Su, Yaqing, Weixiong Yang, Zicheng Sun, et al.. (2025). Disruption of NF‐κB‐Mediated Copper Homeostasis Sensitizes Breast Cancer to Cuproptosis. Advanced Science. 12(47). e06201–e06201. 1 indexed citations
5.
Guo, Fangzhou, Weixiong Yang, Shi‐Ting Feng, et al.. (2023). Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell carcinoma. European Journal of Cancer. 186. 196–210. 12 indexed citations
7.
Wang, Xiaoyan, Weixiong Yang, Qian Zhou, et al.. (2022). The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4241–4251. 24 indexed citations
8.
Wang, Xiaoli, et al.. (2022). Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p/PBX3 axis. Hematology. 27(1). 951–959. 5 indexed citations
9.
Yang, Weixiong, Chang‐Han Chen, Minghan Jia, et al.. (2021). Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 641270–641270. 43 indexed citations
10.
Zeng, Bo, Zhenguo Liu, Xin Zhang, et al.. (2021). CircRNA_2646 functions as a ceRNA to promote progression of esophageal squamous cell carcinoma via inhibiting miR-124/PLP2 signaling pathway. Cell Death Discovery. 7(1). 99–99. 10 indexed citations
11.
Guo, Yan, Chao Cheng, Yu Zeng, et al.. (2020). Mental Health Disorders and Associated Risk Factors in Quarantined Adults During the COVID-19 Outbreak in China: Cross-Sectional Study. Journal of Medical Internet Research. 22(8). e20328–e20328. 111 indexed citations
13.
Zhang, Shuishen, Minghan Jia, Xiaoli Cai, et al.. (2020). Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients. Frontiers in Oncology. 10. 586084–586084. 2 indexed citations
14.
Yang, Weixiong, Na You, Minghan Jia, et al.. (2020). Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer. 146. 327–334. 15 indexed citations
15.
Yang, Yaping, Jieqiong Liu, Min Peng, et al.. (2020). Introduction of a multicenter online database for non-metastatic breast cancer in China. Science China Life Sciences. 63(9). 1417–1420. 9 indexed citations
16.
Zeng, Bo, et al.. (2020). A Modified VATS Procedure for Treating Adult Intralobar Pulmonary Sequestration. The Thoracic and Cardiovascular Surgeon. 69(2). 194–196. 2 indexed citations
17.
Chen, Yuxia, Yuanqi Zhang, Weixiong Yang, et al.. (2018). Accuracy of a nomogram to predict the survival benefit of surgical axillary staging in T1 breast cancer patients. Medicine. 97(26). e11273–e11273. 5 indexed citations
18.
Wang, Shuai, Pengfei Xing, Shuaibo Gao, et al.. (2018). Effect of in-situ formed CrB2 on pressureless sintering of B4C. Ceramics International. 44(16). 20367–20374. 23 indexed citations
19.
Yang, Weixiong, Canqiao Luo, Zhenguo Liu, & Chao Cheng. (2017). Chylous pericardial effusion after pulmonary lobectomy. Interactive Cardiovascular and Thoracic Surgery. 25(1). 145–146.
20.
Liu, Zhenguo, Canqiao Luo, Weixiong Yang, et al.. (2017). Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. Cancer Biology & Therapy. 19(1). 34–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026